The DOI matches its Crossref record.
Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cited by
Current treatment of non‐alcoholic fatty liver disease
Paternostro, R., & Trauner, M. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13531 · Cited by 305
Therapeutic pipeline in nonalcoholic steatohepatitis
Vuppalanchi, R., Noureddin, M., Alkhouri, N., & Sanyal, A. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00408-y · Cited by 278
Self-citationBurra, P., Bizzaro, D., Gonta, A., Shalaby, S., Gambato, M., Morelli, M. C., Trapani, S., Floreani, A., Marra, F., Brunetto, M. R., et al. (2021) · Liver International · doi:10.1111/liv.14943 · Cited by 162
Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update
Chew, N., Ng, C. H., Truong, E., Noureddin, M., & Kowdley, K. V. (2022) · Seminars in Liver Disease · doi:10.1055/a-1877-9656 · Cited by 51
Self-citationEmerging synthetic drugs for the treatment of liver cirrhosis
Fallowfield, J. A., Ramos, M. J., & Robertson, A. (2021) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2021.1918099 · Cited by 41
Metadata
- Authors
- Loomba, R., Noureddin, M., Kowdley, K., Kohli, A., Sheikh, A., Neff, G., Bhandari, B. R., Gunn, N. T., Caldwell, S., Goodman, Z., Wapinski, I., Resnick, M., Beck, A., Ding, D., Jia, C., Huss, R., Chung, C., Subramanian, M., Myers, R., Patel, K., Borg, B., Ghalib, R., Kabler, H., Poulos, J., Younes, Z. H., Elkhashab, M., Hassanein, T., Iyer, R., Ruane, P., Shiffman, M., Strasser, S., Wong, V. W.-S., & Alkhouri, N.
- Affiliations
- University of California San Diego (US)
- Cedars-Sinai Medical Center (US)
- Liver Institute Northwest (US)
- Arizona Liver Health (US)
- GI Specialists of Georgia (United States) (US)
- Covenant Research and Clinics (United States) (US)
- Pinnacle Clinical Research (US)
- University of Virginia (US)
- Inova Fairfax Hospital (US)
- PathAI (United States) (US)
- Gilead Sciences (United States) (US)
- University of Toronto (CA)
- Centre Hospitalier Universitaire de Nice (FR)
- Centre Hospitalier Universitaire de Nantes (FR)
- Cumberland Research Associates (United States) (US)
- Centre Hospitalier Universitaire de Poitiers (FR)
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
- Iowa Digestive Disease Center (US)
- Ruane Medical (US)
- Bon Secours Mercy Health (US)
- The University of Sydney (AU)
- Chinese University of Hong Kong (HK)
- Texas Liver Institute (US)
- Corresponding author
- Huss, Ryan
- ORCID
- Loomba, Rohit
- Noureddin, Mazen
- Kowdley, Kris
- Kohli, Anita
- Sheikh, Aasim
- Neff, Guy
- Gunn, Nadege T.
- Caldwell, Stephen
- Goodman, Zachary
- Resnick, Murray
- Beck, Andrew
- Huss, Ryan
- Chung, Chuhan
- Patel, Keyur
- Borg, Brian
- Kabler, Heidi
- Younes, Ziad H.
- Hassanein, Tarek
- Iyer, Rajalakshmi
- Ruane, Peter
- Shiffman, Mitchell
- Strasser, Simone
- Wong, Vincent Wai-Sun
- Alkhouri, Naim
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 73
- Pages
- S116-S117
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4246217891
- Cited by
- 9
- References
- 0
- Citations by year
- 2022: 2 · 2021: 7
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Hepatology (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- severe alcoholic hepatitis, early liver transplantation, non-inferiority, alcohol relapse, Lille score, MELD score, heavy drinking, post-transplant survival, alcoholic cirrhosis, NASH, liver cirrhosis, fibrosis, combination therapy, ATLAS trial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial. https://app.cochat.ai/papers/10.1016/s0168-8278(20)30753-4
- The paper
- Loomba, R., Noureddin, M., Kowdley, K., Kohli, A., Sheikh, A., Neff, G., Bhandari, B. R., Gunn, N. T., Caldwell, S., Goodman, Z., Wapinski, I., Resnick, M., Beck, A., Ding, D., Jia, C., Huss, R., Chung, C., Subramanian, M., Myers, R., . . . Alkhouri, N. (2020). Safety and efficacy of combination therapies including cilofexor/ firsocostat in patients with bridging fibrosis and cirrhosis due to NASH: Results of the phase 2b ATLAS trial. Journal of Hepatology. https://doi.org/10.1016/s0168-8278(20)30753-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.